In January 2021, in addition to revising the Self-Care Advertising Code (see our article here), the Irish Pharmaceutical Healthcare Association (IPHA) released the latest edition (edition 8.5) of its Code of Practice for the Pharmaceutical Industry (Code), which will take effect on 1 March 2021 and applies to prescription-only medicines.
Various scandals within the pharmaceutical industry over the last few years involving pharmaceutical companies, doctors and hospitals, sparked a push to strengthen the existing Code.
In our briefing we cover:
- Key Changes
- Inclusion of the EFPIA Ethical Principles
- Transfers of Value Disclosures
- Further Requirements Regarding Patient Organisation (PO) Funding
- Definitions
- Other Key Changes
- Effect of the Code
Please click here or on the image below to download our briefing.
Contributed by Florence Meagher & Louise Murray
Recommended Insights
Article and Insights
1
Nov 2024
We are delighted to announce that Stephen Keogh has formally taken up the role of ...
Managing Partner
Stephen Keogh
Article and Insights
1
Nov 2024
On 31 October 2024, the Minister of State for Trade Promotion, Digital and Company...
Partner
Barry Scannell
Article and Insights
29
Oct 2024
William Fry's Financial Regulation team examines key themes highlighted by the Cen...
Partner
Shane Kelleher
Article and Insights
5
Nov 2024
The Government has approved and published the Terms and Conditions for Ireland's s...
Partner
Fergus Devine
Article and Insights
25
Oct 2024
William Fry is pleased to have acted as lead Irish counsel to Grant Thornton Advis...
Partner
Ivor Banim
Article and Insights
24
Oct 2024
Privy Council decision on arbitration agreements in insolvency cases.
Partner
Ruairi Rynn
prev
next